Pfizer sues Amgen in effort to invalidate top cancer drug patent
Pfizer is suing Amgen in Europe over a patent issue, one in which both companies have long gone back and forth.
The brouhaha centers around …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
